Matthew A Cerny

6PUBLICATIONS
29CO-AUTHORS
Characterisation of biological macromoleculesEpigenetics (incl. genome methylation and epigenomics)Molecular targetsToxicology (incl. clinical toxicology)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2026
Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans.

|Jan 02, 2025
Design and application of synthetic 17B-HSD13 substrates reveals preserved catalytic activity of protective human variants.

Michelle R Garnsey, Yang Wang, David J Edmonds

|Aug 07, 2024
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans.

Jonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri

|Jul 30, 2021
Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes.

Elaine Tseng, Heather Eng, Jian Lin

|Apr 03, 2021
Cytochrome P450 3A Time-Dependent Inhibition Assays Are Too Sensitive for Identification of Drugs Causing Clinically Significant Drug-Drug Interactions: A Comparison of Human Liver Microsomes and Hepatocytes and Definition of Boundaries for Inactivation Rate Constants.

Heather Eng, Elaine Tseng, Matthew A Cerny

|Aug 03, 2018
Identification and Characterization of a Selective Human Carbonyl Reductase 1 Substrate.

Diane Ramsden, Dustin Smith, Raquel Arenas

Pageof 1

Frequent Collaborators

3 joint publications

Heather Eng

2 joint publications

Theunis C Goosen

2 joint publications

R Scott Obach

1 joint publications

Dustin Smith